Growth Metrics

RxSight (RXST) Change in Account Payables (2020 - 2026)

RxSight filings provide 6 years of Change in Account Payables readings, the most recent being $2.2 million for Q4 2025.

  • On a quarterly basis, Change in Account Payables rose 1800.0% to $2.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $627000.0, a 33.72% decrease, with the full-year FY2025 number at $627000.0, down 33.72% from a year prior.
  • Change in Account Payables hit $2.2 million in Q4 2025 for RxSight, up from -$86000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $2.2 million in Q1 2025 to a low of -$3.7 million in Q2 2025.
  • Median Change in Account Payables over the past 5 years was $138500.0 (2023), compared with a mean of $200650.0.
  • Biggest five-year swings in Change in Account Payables: plummeted 1779.21% in 2022 and later skyrocketed 1800.0% in 2025.
  • RxSight's Change in Account Payables stood at $101000.0 in 2021, then plummeted by 1779.21% to -$1.7 million in 2022, then soared by 90.68% to -$158000.0 in 2023, then skyrocketed by 173.42% to $116000.0 in 2024, then skyrocketed by 1800.0% to $2.2 million in 2025.
  • The last three reported values for Change in Account Payables were $2.2 million (Q4 2025), -$86000.0 (Q3 2025), and -$3.7 million (Q2 2025) per Business Quant data.